NET PROFIT (x1000 DKK)
EMPLOYEES
Danipharm A/S
Closing information (x1000 DKK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
6,906
|
10,499
|
3,772 |
| Total assets |
87,076
|
78,307
|
73,178 |
| Current assets |
74,070
|
63,345
|
56,105 |
| Current liabilities |
43,781
|
40,447
|
38,301 |
| Equity capital |
41,450
|
36,059
|
29,869 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
47.6%
|
46.0%
|
40.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
169.2%
|
156.6%
|
146.5% |
| Return on equity (ROE) |
16.7%
|
29.1%
|
12.6% |
| Change turnover |
0
|
0
|
-91,597 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.